FOXO1 and rhabdomyosarcoma: In addition, the much rarer fusions in rhabdomyosarcoma (such as PAX‐NCOA, which are not detectable by FOXO1 FISH or PCR studies) were not looked for, and it is not known at this time how they affect outcome.32 In addition, we only considered pretreatment factors and not therapy received.